Comparison of neoadjuvant immunotherapy plus chemotherapy versus chemotherapy alone for patients with locally advanced esophageal squamous cell carcinoma: A propensity score matching

Comparison of neoadjuvant immunotherapy plus chemotherapy versus chemotherapy alone for patients with locally advanced esophageal squamous cell carcinoma: A propensity score matching

ObjectivesClinical studies on immune checkpoint inhibitors (ICIs) combined with neoadjuvant chemotherapy (nCT) have been carried out for the resectable esophageal squamous cell carcinoma (ESCC). So far, few studies have compared the survival outcomes of nCT plus ICIs and nCT alone. This study aimed...

Full description

Bibliographic Details
Main Authors: Shao-Wu Jing, Chang Zhai, Wei Zhang, Ming He, Qing-Yi Liu, Ji-Fang Yao, Rui Wang, Zi-Qiang Tian, Jun Wang, Jun-Feng Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
esophageal squamous cell carcinoma
neoadjuvant chemotherapy
immune checkpoint inhibitors
esophagectomy (or surgery)
propensity score matching
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.970534/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.970534/full

Similar Items